Literature DB >> 7581221

Bromocriptine and lactation suppression: are the risks acceptable?

L de Jong-van den Berg, B Mintzes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7581221     DOI： 10.1007/BF01872384

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN： 0928-1231


× No keyword cloud information.
  4 in total

1.  [Bromocriptine, lactation inhibition and drug monitoring].

Authors:  A Fournié; V Graille; J L Montastruc
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  1994

2.  Bromocriptine and puerperal seizures.

Authors:  K J Rothman; D P Funch; N A Dreyer
Journal:  Epidemiology       Date:  1990-05       Impact factor: 4.822

3.  Bromocriptine and suppression of postpartum lactation. The incidence of adverse cardiovascular effects in women of child-bearing age.

Authors:  R M Herings; B H Stricker
Journal:  Pharm World Sci       Date:  1995-07-28

4.  Bromocriptine mesylate for lactation suppression: a risk for postpartum hypertension?

Authors:  D L Watson; R K Bhatia; G S Norman; B A Brindley; R J Sokol
Journal:  Obstet Gynecol       Date:  1989-10       Impact factor: 7.661
  4 in total
  1 in total

Review 1.  Review of Presentation, Diagnosis and Management of Pituitary Tumours in Pregnancy.

Authors:  Kimberley Lambert; Catherine Williamson
Journal:  Obstet Med       Date:  2013-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.